Krebs Biochemicals & Industries Board of Directors
Get the latest insights into the leadership at Krebs Biochemicals & Industries. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Dr. R T Ravi | Chairman & Non-Exe.Director |
| Mr. Manish Kumar Jain | Managing Director & CEO |
| Mr. P K Bhattacharyya | Non Executive Director |
| Mr. Avinash Ravi | Non Executive Director |
| Mr. P M Kathariya | Independent Director |
| Ms. Dipti Shah | Independent Director |
| Mr. Satya Prakash Chigurupati | Independent Director |
| Mr. Sumanth Karlapudi | Independent Director |
Krebs Biochemicals & Industries Share price
KREBSBIO
73.45
2.52 (-3.32%)NSE
BSE
Last updated on 25 Sep, 2025 | 15:48 IST
BUYSELL
Today's High
76.80
Today's Low
73.33
52 Week Low
66.12
52 Week High
129.07
The current prices are delayed, login to your account for live prices
LoginKrebs Biochemicals & Industries FAQs
The board at Krebs Biochemicals & Industries consists of experienced professionals, including Dr. R T Ravi , Mr. Manish Kumar Jain , and others, overseeing the company’s strategic and corporate governance.
Directors at Krebs Biochemicals & Industries are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Dr. R T Ravi is the current chairman at Krebs Biochemicals & Industries.
Executive directors at Krebs Biochemicals & Industries are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Krebs Biochemicals & Industries adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Krebs Biochemicals & Industries, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.